Barinthus Biotherapeutics plc American (BRNS) Total Assets by Year
Barinthus Biotherapeutics plc American closed fiscal year 2025 with $98.2M in total assets, $23.9M in total liabilities and $74.2M in shareholder equity. This represents a decrease of 38.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Barinthus Biotherapeutics plc American has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BRNS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BRNS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $81.9M-36.8% | $92.1M-35.1% | $98.2M-38.8% | $109.2M-42.1% | $129.6M-30.6% | $142.0M-28.8% | $160.3M-25.3% | $188.7M-18.0% | $186.7M-24.1% | $199.5M-23.8% | $214.5M-20.6% | $230.0M-16.5% |
| Total Liabilities | $24.8M-8.6% | $25.7M-2.8% | $23.9M-20.9% | $24.6M-15.7% | $27.1M-9.6% | $26.4M-3.9% | $30.2M+9.7% | $29.2M-15.0% | $30.0M+4.5% | $27.5M-2.8% | $27.5M+1.9% | $34.4M+9.7% |
| Total Equity | $57.1M-44.3% | $66.4M-42.5% | $74.2M-42.9% | $84.5M-47.0% | $102.4M-34.6% | $115.5M-32.8% | $130.0M-30.4% | $159.3M-18.5% | $156.6M-27.9% | $171.8M-26.3% | $186.8M-23.1% | $195.4M-19.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Barinthus Biotherapeutics plc American financials
Frequently Asked Questions
What was Barinthus Biotherapeutics plc American's total assets in fiscal year 2025?
Barinthus Biotherapeutics plc American closed fiscal year 2025 with $98.2M in total assets, $23.9M in total liabilities and $74.2M in shareholder equity.
How fast is Barinthus Biotherapeutics plc American's total assets growing?
Barinthus Biotherapeutics plc American (BRNS) total assets fell by 38.8% year over year, from $160.3M to $98.2M in fiscal year 2025.
How has Barinthus Biotherapeutics plc American's total assets changed over the years?
Across the 6 fiscal years this page covers, Barinthus Biotherapeutics plc American (BRNS) total assets went from $50.7M in fiscal year 2020 to $98.2M in fiscal year 2025.
What was Barinthus Biotherapeutics plc American's total assets in the most recent quarter?
Barinthus Biotherapeutics plc American (BRNS) reported $81.9M in total assets in Q2 2026. This represents a decrease of 36.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Barinthus Biotherapeutics plc American (BRNS) reported on that line in every period on record.